Science Explorer Back to mapMap
Discussion
Company · Uppsala · Sweden

Ilya Pharma (Sweden)

ilyapharma.seROR OpenAlex
Research works
5
▲ 32% vs 2018-21
Citations
137
28.8 per fractional work
Top-10% rate
15.9%
all institutions 10.0%
Open access
60%
world 40%
International
15%
world 18%
Ilya Pharma (Sweden)

Not ranked overall: Ilya Pharma (Sweden) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Ilya Pharma (Sweden) work in?

In all years, 57% of research at Ilya Pharma (Sweden) is in Life Sciences, 43% in Health Sciences. Its largest fields are Medicine (43%), Biochemistry, Genetics and Molecular Biology (34%), Immunology and Microbiology (17%). It does 1.5× the world's share of Life Sciences.

Life Sciences: 3 fractional works · 57.4% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 34.0% of its workImmunology and Microbiology: 1 fractional works · 17.0% of its workAgricultural and Biological Sciences: 0 fractional works · 6.4% of its workHealth Sciences: 2 fractional works · 42.6% of its workMedicine: 2 fractional works · 42.6% of its workALL ITS WORKIlya Pharma(Sweden)5fractional works, all years
Life Sciences57%Health Sciences43%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 4 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology234.0%
    2. Immunology and Microbiology117.0%
    3. Agricultural and Biological Sciences06.4%
    1. Medicine242.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Ilya Pharma (Sweden)?

The most cited paper from Ilya Pharma (Sweden) is "Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus" (Emma Eriksson, Ioanna E. Milenova, Jessica Wenthe et al., 2017), with 156 citations. Next come "The discovery and development of topical medicines for wound healing" (113) and "Engineered bacteria to accelerate wound healing: an adaptive, randomised, double-blind, placebo-controlled, first-in-human phase 1 trial" (46).

Most cited papers
#PaperReleasedCitations
1 Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus Emma Eriksson, Ioanna E. Milenova, Jessica Wenthe et al. · Clinical Cancer Research 23 May 2017 156
2 The discovery and development of topical medicines for wound healing Emelie Öhnstedt, Hava Lofton Tomenius, Evelina Vågesjö et al. · Expert Opinion on Drug Discovery Open access 14 Mar 2019 113
3 Engineered bacteria to accelerate wound healing: an adaptive, randomised, double-blind, placebo-controlled, first-in-human phase 1 trial Emelie Öhnstedt, Evelina Vågesjö, Andreas E. R. Fasth et al. · EClinicalMedicine Open access 25 May 2023 46
4 A phase 2a clinical study on the safety and efficacy of individualized dosed mebendazole in patients with advanced gastrointestinal cancer Sharmineh Mansoori, Mårten Fryknäs, Carina Alvfors et al. · Scientific Reports Open access 26 Apr 2021 33
5 Accelerated Wound Healing in Minipigs by On-Site Production and Delivery of CXCL12 by Transformed Lactic Acid Bacteria Emelie Öhnstedt, Hava Lofton Tomenius, Peter Frank et al. · Pharmaceutics Open access 19 Jan 2022 26
All 13 most cited papers, with filters and sorting

Which research topics does Ilya Pharma (Sweden) publish most on?

By volume in 2022-now: Virus-based gene therapy research, Cancer Research and Treatments, CAR-T cell therapy research and Viral gastroenteritis research and epidemiology.

Virus-based gene therapy research: 0 fractional worksCancer Research and Treatments: 0 fractional worksCAR-T cell therapy research: 0 fractional worksViral gastroenteritis research and epidemiology: 0 fractional worksAntimicrobial Peptides and Activities: 0 fractional worksImmune Response and Inflammation: 0 fractional worksWound Healing and Treatments: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional worksProbiotics and Fermented Foods: 0 fractional worksPlanarian Biology and Electrostimulation: 0 fractional works
GeneticsBiotechnologyOncologyInfectious Diseases5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Virus-based gene therapy research Genetics 0 works
  2. 2 Cancer Research and Treatments Biotechnology 0 works
  3. 3 CAR-T cell therapy research Oncology 0 works
  4. 4 Viral gastroenteritis research and epidemiology Infectious Diseases 0 works
  5. 5 Antimicrobial Peptides and Activities Microbiology 0 works
  6. 6 Immune Response and Inflammation Immunology 0 works
  7. 7 Wound Healing and Treatments Rehabilitation 0 works
  8. 8 Immunotherapy and Immune Responses Immunology 0 works
  9. 9 Probiotics and Fermented Foods Food Science 0 works
  10. 10 Planarian Biology and Electrostimulation Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available59.7%not open40.3%

World: 40% of research is openly available.

with international co-authors14.6%domestic only85.4%

World: 18% is written across borders.

How has Ilya Pharma (Sweden)'s research output changed?

Output in 2022-2025 was 32% higher than in 2018-2021.

still counting20202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Uppsala

All research institutions in Uppsala

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Ilya Pharma (Sweden). Posts are plain text and can be reported.